Wird geladen...

Targeting mTOR and Glycolysis in HER2-Positive Breast Cancer

SIMPLE SUMMARY: About one third of all breast cancers are classified as HER2-positive due to high levels of the HER2 cell surface protein. Drugs that target HER2 have been mostly successful, but this type of cancer returns at a high frequency once treatment has been completed. The high levels of HER...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancers (Basel)
Hauptverfasser: Holloway, Ryan W., Marignani, Paola A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8230691/
https://ncbi.nlm.nih.gov/pubmed/34208071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13122922
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!